{"cdcTestId":"2013-0429","testcaseName":"#2 @ 11 yrs \u002B 2 mo, female, Cervarix ","vaccineGroup":"HPV","evaluationTestType":"Interval: At Minimum","forecastTestType":"Recommended based on interval","assessmentDate":"2011-07-01T00:00:00","patient":{"dob":"2000-05-01T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2011-05-01T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2011-07-01T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2011-10-01T00:00:00","recommendedDate":"2011-11-01T00:00:00","pastDueDate":"2012-06-28T00:00:00"},"doses":[{"dateAdministered":"2011-05-01T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2011-07-01T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-10-05T15:41:00.416","generalDescription":"This test case describes when a patient is administered a second dose of the HPV vaccine at 11 years and 2 months of age (8 weeks after the previous dose) that the dose is valid.  Another dose should be forecast.","changedInVersion":"3.2","reasonForChange":"Updated to reflect ACIP recommendations for the HPV 2 dose series."}